Westmount Partners’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,000
| Closed | -$10.6K | – | 223 |
|
|
2024
Q1 | $10.6K | Sell |
10,000
-148
| -1% | -$157 | ﹤0.01% | 212 |
|
|
2023
Q4 | $10.7K | Hold |
10,148
| – | – | ﹤0.01% | 201 |
|
|
2023
Q3 | $11.4K | Hold |
10,148
| – | – | 0.01% | 192 |
|
|
2023
Q2 | $15.3K | Hold |
10,148
| – | – | 0.01% | 186 |
|
|
2023
Q1 | $15.8K | Hold |
10,148
| – | – | 0.01% | 183 |
|
|
2022
Q4 | $6.47K | Buy |
+10,148
| New | +$6.47K | ﹤0.01% | 172 |
|